The Addition of CD20 Monoclonal Antibodies to Lenalidomide Improves Response Rates and Survival in Relapsed/refractory patients with CLL Relative to Lenalidomide Monotherapy – The MD Anderson Cancer Center Experience

Na minha lista:
書目詳細資料
發表在:Br J Haematol
Main Authors: Thompson, Philip A., Rosovski, Uri, Keating, Michael J., Stingo, Francesco, Smith, Susan C., Wierda, William G., Falchi, Lorenzo, O'Brien, Susan M., Estrov, Zeev, Burger, Jan A., Ferrajoli, Alessandra
格式: Artigo
語言:Inglês
出版: 2015
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4589497/
https://ncbi.nlm.nih.gov/pubmed/25824652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13377
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍